Researchers have made more advancements in multiple sclerosis in the last five years than in the previous 70 years. Knowing ...

The FDA issued a boxed warning for anaphylaxis risk linked to Glatiramer acetate and Glatopa, used in MS treatment.

Migraine may be a symptom of prodromal multiple sclerosis (MS), as the risk for migraine gradually increased closer to the ...

Mikael Simons, MD, a neurologist and researcher at Technical University Munich and the Centre for Neurodegenerative Diseases ...

Formerly believed to predominantly affect Caucasians, new research indicates that MS actually may hit Blacks the hardest.

Multiple sclerosis (MS) is one of the most widespread ... They may order tests if you have symptoms of MS, and they can advise on a suitable treatment plan after confirming the diagnosis.

MS patients who achieve long-term stable disease on disease-modifying therapy may want to stop their medication for varying ...

Reports of anaphylaxis associated with the use of glatiramer acetate have prompted the Food and Drug Administration (FDA) to add a Boxed Warning to the prescribing information.

The National Multiple Sclerosis Society lists a variety of sample medications commonly prescribed to manage a variety of common symptoms of MS. The disease process of MS often tends to go into ...

Listen to Post Strategies to ease the burden Multiple Sclerosis (MS) is a chronic neurological condition that ...

Teva Pharmaceutical’s Copaxone was approved by the FDA in 1996 to treat relapsing forms of MS, an autoimmune disorder that ...